P39688 (FYN_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 137.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Tyrosine-protein kinase Fyn EC=2.7.10.2 Alternative name(s): Proto-oncogene c-Fyn p59-Fyn | ||
| Gene names |
| ||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||
| Taxonomic identifier | 10090 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 537 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Non-receptor tyrosine-protein kinase that plays a role in many biological processes including regulation of cell growth and survival, cell adhesion, integrin-mediated signaling, cytoskeletal remodeling, cell motility, immune response and axon guidance. Inactive FYN is phosphorylated on its C-terminal tail within the catalytic domain. Following activation by PKA, the protein subsequently associates with PTK2/FAK1, allowing PTK2/FAK1 phosphorylation, activation and targeting to focal adhesions. Involved in the regulation of cell adhesion and motility through phosphorylation of CTNNB1 (beta-catenin) and CTNND1 (delta-catenin). Regulates cytoskeletal remodeling by phosphorylating several proteins including the actin regulator WAS and the microtubule-associated proteins MAP2 and MAPT. Promotes cell survival by phosphorylating AGAP2/PIKE-A and preventing its apoptotic cleavage. Participates in signal transduction pathways that regulate the integrity of the glomerular slit diaphragm (an essential part of the glomerular filter of the kidney) by phosphorylating several slit diaphragm components including NPHS1, KIRREL and TRPC6. Plays a role in neural processes by phosphorylating DPYSL2, a multifunctional adapter protein within the central nervous system, ARHGAP32, a regulator for Rho family GTPases implicated in various neural functions, and SNCA, a small pre-synaptic protein. Participates in the downstream signaling pathways that lead to T-cell differentiation and proliferation following T-cell receptor (TCR) stimulation. Also participates in negative feedback regulation of TCR signaling through phosphorylation of PAG1, thereby promoting interaction between PAG1 and CSK and recruitment of CSK to lipid rafts. CSK maintains LCK and FYN in an inactive form. Promotes CD28-induced phosphorylation of VAV1 By similarity. Ref.11 Ref.16 Ref.17 Ref.19 |
| Catalytic activity | ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate. |
| Cofactor | Manganese. |
| Enzyme regulation | Inhibited by phosphorylation of Tyr-531 by leukocyte common antigen and activated by dephosphorylation of this site. Ref.7 |
| Subunit structure | Interacts (via its SH3 domain) with PIK3R1 and PRMT8. Interacts with FYB, PAG1, and SH2D1A. Interacts with CD79A (tyrosine-phosphorylated form); the interaction increases FYN activity. Interacts with TOM1L1 (phosphorylated form). Interacts with SH2D1A and SLAMF1. Interacts with and phosphorylates ITCH, down-regulating its activity. Interacts with FASLG. Interacts with RUNX3. Interacts with KIT. Interacts with EPHA8; possible downstream effector of EPHA8 in regulation of cell adhesion. Interacts with PTK2/FAK1; this interaction leads to PTK2/FAK1 phosphorylation and activation. Interacts with CAV1; this interaction couples integrins to the Ras-ERK pathway. Interacts (via SH3 domain) with KLHL2 (via N-terminus) By similarity. Interacts with KDR (tyrosine phosphorylated). Interacts (via SH2 domain) with CSF1R (tyrosine phosphorylated). Ref.6 Ref.10 Ref.13 Ref.15 Ref.21 |
| Subcellular location | Cytoplasm By similarity. Nucleus By similarity. Cell membrane By similarity. Note: Present and active in lipid rafts. Palmitoylation is crucial for proper trafficking By similarity. Ref.16 Ref.18 |
| Tissue specificity | Isoform 1 is highly expressed in the brain, isoform 2 is expressed in cells of hemopoietic lineages, especially T-lymphocytes. Ref.5 Ref.11 |
| Post-translational modification | Autophosphorylated at Tyr-420. Phosphorylation on the C-terminal tail at Tyr-531 by CSK maintains the enzyme in an inactive state. PTPRC/CD45 dephosphorylates Tyr-531 leading to activation. ultraviolet B (UVB) strongly increase phosphorylation at Thr-15 and kinase activity, and promotes translocation from the cytoplasm to the nucleus By similarity. Ref.7 Palmitoylation at Cys-3 and Cys-6 regulates subcellular location. Ref.8 Ref.9 Ref.14 Myristoylation is required prior to palmitoylation. Ref.8 Ref.9 Ref.14 |
| Disruption phenotype | Mice have various neural defects, including defective long term potentiation, impaired spatial memory, hypomyelination, abnormal dendrite orientation and uncoordinated hippocampal structure. Ref.5 Ref.25 |
| Sequence similarities | Belongs to the protein kinase superfamily. Tyr protein kinase family. SRC subfamily. Contains 1 protein kinase domain. Contains 1 SH2 domain. Contains 1 SH3 domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| Dynlt1 | P51807 | 3 | EBI-524514,EBI-642797 | |
| Khdrbs1 | Q60749 | 13 | EBI-524514,EBI-519077 | |
| PLXNA2 | O75051 | 3 | EBI-524514,EBI-308264 | From a different organism. |
| Sphk2 | Q9JIA7 | 2 | EBI-524514,EBI-985434 |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P39688-1) Also known as: B; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P39688-2) Also known as: T; The sequence of this isoform differs from the canonical sequence as follows: 234-236: RAA → KAD 240-287: CRLVVPCHKG...GNGQFGEVWM → FNLTVVSSSC...GQGCFAEVWL |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 537 | 537 | Tyrosine-protein kinase Fyn | PRO_0000088100 | |||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||
| Domain | 82 – 143 | 62 | SH3 | ||||||||||||||||||||||||||||||||
| Domain | 149 – 246 | 98 | SH2 | ||||||||||||||||||||||||||||||||
| Domain | 271 – 524 | 254 | Protein kinase | ||||||||||||||||||||||||||||||||
| Nucleotide binding | 277 – 285 | 9 | ATP By similarity | ||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||
| Active site | 390 | 1 | Proton acceptor By similarity | ||||||||||||||||||||||||||||||||
| Binding site | 299 | 1 | ATP By similarity | ||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||
| Modified residue | 15 | 1 | Phosphothreonine By similarity | ||||||||||||||||||||||||||||||||
| Modified residue | 21 | 1 | Phosphoserine | ||||||||||||||||||||||||||||||||
| Modified residue | 25 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||||||||||
| Modified residue | 185 | 1 | Phosphotyrosine Ref.22 | ||||||||||||||||||||||||||||||||
| Modified residue | 213 | 1 | Phosphotyrosine By similarity | ||||||||||||||||||||||||||||||||
| Modified residue | 214 | 1 | Phosphotyrosine By similarity | ||||||||||||||||||||||||||||||||
| Modified residue | 254 | 1 | Phosphothreonine Ref.24 | ||||||||||||||||||||||||||||||||
| Modified residue | 257 | 1 | Phosphoserine Ref.24 | ||||||||||||||||||||||||||||||||
| Modified residue | 420 | 1 | Phosphotyrosine; by autocatalysis Ref.7 Ref.23 | ||||||||||||||||||||||||||||||||
| Modified residue | 440 | 1 | Phosphotyrosine By similarity | ||||||||||||||||||||||||||||||||
| Modified residue | 512 | 1 | Phosphothreonine By similarity | ||||||||||||||||||||||||||||||||
| Modified residue | 531 | 1 | Phosphotyrosine; by CSK By similarity | ||||||||||||||||||||||||||||||||
| Lipidation | 2 | 1 | N-myristoyl glycine Ref.12 | ||||||||||||||||||||||||||||||||
| Lipidation | 3 | 1 | S-palmitoyl cysteine Ref.8 Ref.9 Ref.14 | ||||||||||||||||||||||||||||||||
| Lipidation | 6 | 1 | S-palmitoyl cysteine Probable | ||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||
| Alternative sequence | 234 – 236 | 3 | RAA → KAD in isoform 2. | VSP_024111 | |||||||||||||||||||||||||||||||
| Alternative sequence | 240 – 287 | 48 | CRLVV…GEVWM → FNLTVVSSSCTPQTSGLAKD AWEVARDSLFLEKKLGQGCF AEVWL in isoform 2. | VSP_024112 | |||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||
| Mutagenesis | 2 | 1 | G → A: Abolishes myristoylation and palmitoylation. Ref.9 | ||||||||||||||||||||||||||||||||
| Mutagenesis | 3 | 1 | C → A: Abolishes palmitoylation and plasma membrane association; when associated with A-6. Ref.8 Ref.9 Ref.14 | ||||||||||||||||||||||||||||||||
| Mutagenesis | 3 | 1 | C → S: Abolishes palmitoylation and plasma membrane association; when associated with S-6. Abolishes plasma membrane association. Ref.8 Ref.9 Ref.14 | ||||||||||||||||||||||||||||||||
| Mutagenesis | 6 | 1 | C → A: Abolishes palmitoylation and plasma membrane association; when associated with A-3. Ref.8 Ref.9 | ||||||||||||||||||||||||||||||||
| Mutagenesis | 6 | 1 | C → S: Abolishes palmitoylation and plasma membrane association; when associated with S-3. Ref.8 Ref.9 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 179 | 1 | E → Q in AAA37644. Ref.1 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 179 | 1 | E → Q in AAB09568. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 432 | 1 | W → R in BAE42585. Ref.3 | ||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||
| Beta strand | 87 – 91 | 5 | |||||||||||||||||||||||||||||||||
| Beta strand | 108 – 113 | 6 | |||||||||||||||||||||||||||||||||
| Beta strand | 115 – 124 | 10 | |||||||||||||||||||||||||||||||||
| Turn | 125 – 127 | 3 | |||||||||||||||||||||||||||||||||
| Beta strand | 130 – 134 | 5 | |||||||||||||||||||||||||||||||||
| Helix | 135 – 137 | 3 | |||||||||||||||||||||||||||||||||
| Beta strand | 138 – 140 | 3 | |||||||||||||||||||||||||||||||||
| Helix | 156 – 163 | 8 | |||||||||||||||||||||||||||||||||
| Beta strand | 173 – 177 | 5 | |||||||||||||||||||||||||||||||||
| Beta strand | 179 – 181 | 3 | |||||||||||||||||||||||||||||||||
| Beta strand | 185 – 192 | 8 | |||||||||||||||||||||||||||||||||
| Beta strand | 194 – 207 | 14 | |||||||||||||||||||||||||||||||||
| Beta strand | 213 – 216 | 4 | |||||||||||||||||||||||||||||||||
| Beta strand | 221 – 223 | 3 | |||||||||||||||||||||||||||||||||
| Helix | 224 – 233 | 10 | |||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Expression of a novel form of the fyn proto-oncogene in hematopoietic cells." Cooke M.P., Perlmutter R.M. New Biol. 1:66-74(1989) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). |
| [2] | "Two species of mRNAs for the fyn proto-oncogene are produced by an alternative polyadenylation." Lee C., Kim M.G., Jeon S.H., Park D.E., Park S.D., Seong R.H. Mol. Cells 8:746-749(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). Tissue: T-cell. |
| [3] | "The transcriptional landscape of the mammalian genome." Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J. Hayashizaki Y.Science 309:1559-1563(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). Strain: NOD. Tissue: Spleen. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Strain: C57BL/6 and FVB/N. Tissue: Brain and Mammary tumor. |
| [5] | "Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice." Grant S.G., O'Dell T.J., Karl K.A., Stein P.L., Soriano P., Kandel E.R. Science 258:1903-1910(1992) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY, DISRUPTION PHENOTYPE. |
| [6] | "Activation of Src family kinases by colony stimulating factor-1, and their association with its receptor." Courtneidge S.A., Dhand R., Pilat D., Twamley G.M., Waterfield M.D., Roussel M.F. EMBO J. 12:943-950(1993) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH CSF1R. |
| [7] | "Differential effects of expression of the CD45 tyrosine protein phosphatase on the tyrosine phosphorylation of the lck, fyn, and c-src tyrosine protein kinases." Hurley T.R., Hyman R., Sefton B.M. Mol. Cell. Biol. 13:1651-1656(1993) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT TYR-531, AUTOPHOSPHORYLATION AT TYR-420, ENZYME REGULATION. |
| [8] | "Palmitylation of an amino-terminal cysteine motif of protein tyrosine kinases p56lck and p59fyn mediates interaction with glycosyl-phosphatidylinositol-anchored proteins." Shenoy-Scaria A.M., Timson L.K., Kwong J., Shaw A.S., Lublin D.M. Mol. Cell. Biol. 13:6385-6392(1993) [PubMed] [Europe PMC] [Abstract] Cited for: PALMITOYLATION AT CYS-3 AND CYS-6, MUTAGENESIS OF CYS-3 AND CYS-6. |
| [9] | "Palmitoylation of multiple Src-family kinases at a homologous N-terminal motif." Koegl M., Zlatkine P., Ley S.C., Courtneidge S.A., Magee A.I. Biochem. J. 303:749-753(1994) [PubMed] [Europe PMC] [Abstract] Cited for: PALMITOYLATION AT CYS-3 AND CYS-6, MUTAGENESIS OF GLY-2; CYS-3 AND CYS-6. |
| [10] | "Analysis of Ig-alpha-tyrosine kinase interaction reveals two levels of binding specificity and tyrosine phosphorylated Ig-alpha stimulation of Fyn activity." Clark M.R., Johnson S.A., Cambier J.C. EMBO J. 13:1911-1919(1994) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH CD79A. |
| [11] | "Unique catalytic properties dictate the enhanced function of p59fynT, the hemopoietic cell-specific isoform of the Fyn tyrosine protein kinase, in T cells." Davidson D., Viallet J., Veillette A. Mol. Cell. Biol. 14:4554-4564(1994) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, TISSUE SPECIFICITY. |
| [12] | "Multiple features of the p59fyn src homology 4 domain define a motif for immune-receptor tyrosine-based activation motif (ITAM) binding and for plasma membrane localization." Gauen L.K.T., Linder M.E., Shaw A.S. J. Cell Biol. 133:1007-1015(1996) [PubMed] [Europe PMC] [Abstract] Cited for: MYRISTOYLATION AT GLY-2. |
| [13] | "Sequential activation of phoshatidylinositol 3-kinase and phospholipase C-gamma2 by the M-CSF receptor is necessary for differentiation signaling." Bourette R.P., Myles G.M., Choi J.L., Rohrschneider L.R. EMBO J. 16:5880-5893(1997) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH CSF1R. |
| [14] | "Palmitoylation of p59fyn is reversible and sufficient for plasma membrane association." Wolven A., Okamura H., Rosenblatt Y., Resh M.D. Mol. Biol. Cell 8:1159-1173(1997) [PubMed] [Europe PMC] [Abstract] Cited for: PALMITOYLATION AT CYS-3, MUTAGENESIS OF CYS-3. |
| [15] | "'Srcasm: a novel Src activating and signaling molecule." Seykora J.T., Mei L., Dotto G.P., Stein P.L. J. Biol. Chem. 277:2812-2822(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TOM1L1. |
| [16] | "Fyn is essential for tyrosine phosphorylation of Csk-binding protein/phosphoprotein associated with glycolipid-enriched microdomains in lipid rafts in resting T cells." Yasuda K., Nagafuku M., Shima T., Okada M., Yagi T., Yamada T., Minaki Y., Kato A., Tani-Ichi S., Hamaoka T., Kosugi A. J. Immunol. 169:2813-2817(2002) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION. |
| [17] | "p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction." Piedra J., Miravet S., Castano J., Palmer H.G., Heisterkamp N., Garcia de Herreros A., Dunach M. Mol. Cell. Biol. 23:2287-2297(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF CTNNB1. |
| [18] | "Transmembrane phosphoprotein Cbp senses cell adhesion signaling mediated by Src family kinase in lipid rafts." Shima T., Nada S., Okada M. Proc. Natl. Acad. Sci. U.S.A. 100:14897-14902(2003) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION. |
| [19] | "Phosphorylation of tau by fyn: implications for Alzheimer's disease." Lee G., Thangavel R., Sharma V.M., Litersky J.M., Bhaskar K., Fang S.M., Do L.H., Andreadis A., Van Hoesen G., Ksiezak-Reding H. J. Neurosci. 24:2304-2312(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF MAPT. |
| [20] | "Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor." Roskoski R. Jr. Biochem. Biophys. Res. Commun. 337:1-13(2005) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW ON ROLE IN KIT SIGNALING. |
| [21] | "Phosphorylation of Tyr1214 within VEGFR-2 triggers the recruitment of Nck and activation of Fyn leading to SAPK2/p38 activation and endothelial cell migration in response to VEGF." Lamalice L., Houle F., Huot J. J. Biol. Chem. 281:34009-34020(2006) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH KDR. |
| [22] | "Large-scale identification and evolution indexing of tyrosine phosphorylation sites from murine brain." Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P. J. Proteome Res. 7:311-318(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-185 AND TYR-531, MASS SPECTROMETRY. Tissue: Brain. |
| [23] | "The phagosomal proteome in interferon-gamma-activated macrophages." Trost M., English L., Lemieux S., Courcelles M., Desjardins M., Thibault P. Immunity 30:143-154(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-420, MASS SPECTROMETRY. Tissue: Macrophage. |
| [24] | "Large scale localization of protein phosphorylation by use of electron capture dissociation mass spectrometry." Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J. Mol. Cell. Proteomics 8:904-912(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-254 AND SER-257, MASS SPECTROMETRY. Tissue: Embryonic fibroblast. |
| [25] | "Decreased dendritic spine density and abnormal spine morphology in Fyn knockout mice." Babus L.W., Little E.M., Keenoy K.E., Minami S.S., Chen E., Song J.M., Caviness J., Koo S.Y., Pak D.T., Rebeck G.W., Turner R.S., Hoe H.S. Brain Res. 1415:96-102(2011) [PubMed] [Europe PMC] [Abstract] Cited for: DISRUPTION PHENOTYPE. |
| [26] | "Crystal structure of a SH3 and SH2 domains of fyn protein (proto-concogene tyrosine-protein kinase fyn) from Mus musculus at 1.98 a resolution." Joint center for structural genomics (JCSG) Submitted (DEC-2011) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (1.98 ANGSTROMS) OF 81-239. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M27266 mRNA. Translation: AAA37644.1. U70324 mRNA. Translation: AAB09568.1. AK156584 mRNA. Translation: BAE33766.1. AK171646 mRNA. Translation: BAE42585.1. BC032149 mRNA. Translation: AAH32149.1. BC092217 mRNA. Translation: AAH92217.1. | ||||||||||||
| IPI | IPI00322097. IPI00762435. | ||||||||||||
| PIR | A44991. | ||||||||||||
| RefSeq | NP_001116364.1. NM_001122892.1. NP_001116365.1. NM_001122893.1. NP_032080.2. NM_008054.2. | ||||||||||||
| UniGene | Mm.4848. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | P39688. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-198N. | ||||||||||||
| IntAct | P39688. 15 interactions. | ||||||||||||
| MINT | MINT-85422. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | P39688. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | P39688. | ||||||||||||
| PRIDE | P39688. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENSMUST00000063091; ENSMUSP00000057707; ENSMUSG00000019843. ENSMUST00000099967; ENSMUSP00000097547; ENSMUSG00000019843. ENSMUST00000126486; ENSMUSP00000115233; ENSMUSG00000019843. ENSMUST00000135242; ENSMUSP00000117111; ENSMUSG00000019843. ENSMUST00000146287; ENSMUSP00000114188; ENSMUSG00000019843. | ||||||||||||
| GeneID | 14360. | ||||||||||||
| KEGG | mmu:14360. | ||||||||||||
| UCSC | uc007evx.2. mouse. uc007evy.2. mouse. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 2534. | ||||||||||||
| MGI | MGI:95602. Fyn. | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | COG0515. | ||||||||||||
| GeneTree | ENSGT00620000087702. | ||||||||||||
| HOGENOM | HOG000233858. | ||||||||||||
| HOVERGEN | HBG008761. | ||||||||||||
| InParanoid | P39688. | ||||||||||||
| KO | K05703. | ||||||||||||
| OrthoDB | EOG41ZF9H. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Reactome | REACT_107772. Immune System. REACT_115202. Signal Transduction. REACT_115433. Developmental Biology. REACT_127416. Developmental Biology. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P39688. | ||||||||||||
| Bgee | P39688. | ||||||||||||
| CleanEx | MM_FYN. | ||||||||||||
| Genevestigator | P39688. | ||||||||||||
| GermOnline | ENSMUSG00000019843. Mus musculus. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 3.30.505.10. 1 hit. | ||||||||||||
| InterPro | IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR001245. Ser-Thr/Tyr_kinase_cat_dom. IPR000980. SH2. IPR001452. SH3_domain. IPR008266. Tyr_kinase_AS. IPR020635. Tyr_kinase_cat_dom. [Graphical view] | ||||||||||||
| Pfam | PF07714. Pkinase_Tyr. 1 hit. PF00017. SH2. 1 hit. PF00018. SH3_1. 1 hit. [Graphical view] | ||||||||||||
| PRINTS | PR00401. SH2DOMAIN. PR00452. SH3DOMAIN. PR00109. TYRKINASE. | ||||||||||||
| SMART | SM00252. SH2. 1 hit. SM00326. SH3. 1 hit. SM00219. TyrKc. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF56112. Kinase_like. 1 hit. SSF50044. SH3. 1 hit. | ||||||||||||
| PROSITE | PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00109. PROTEIN_KINASE_TYR. 1 hit. PS50001. SH2. 1 hit. PS50002. SH3. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| BindingDB | P39688. | ||||||||||||
| ChEMBL | CHEMBL4517. | ||||||||||||
| ChiTaRS | FYN. mouse. | ||||||||||||
| NextBio | 285821. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | FYN_MOUSE | ||||||||
| Accession | Primary (citable) accession number: P39688 Secondary accession number(s): Q3TAT3, Q3U0T5, Q8K2A3 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
